Results Profit & Loss Statements (Million Baht) Consolidated Financial Statements 2018 2017 +/(-) % Revenues from sales and services 656.71 459.26 197.45 42.99% Gross profit from sales and services 125.50

to 28% 2016 2017 % change million Baht million Baht y-on-y Sales and service income 27,747 31,482 13.5% EBITDA 7,494 8,725 16.4% Net profit 2,316 3,594 55.2% Normalized net profit (NNP)* 2,090 2,918

and Analysis EXECUTIVE SUMMARY ABBREVIATION & OUR PROJECTSFINANCIAL PERFORMANCE FINANCIAL POSITION PROGRESS OF PROJECTS UNDER CONSTRUCTION EXECUTIVE SUMMARY 1 Q2’2020 net profit grew 62.5% y-on-y

Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book

31, 2018 as follows. The net profit of the Corporate Group for Year 2018 was Baht 422.85 million. In comparison with the previous year with the net profit of Baht 411.61 million, the net profit

annualized projected annual net profit of 36.05 percent and there was a decrease in total assets of 3.12 percent from the previous year. (2.5) Financial Position Description Statement of Financial Position

Discussion and Analysis for 2nd quarter ended as of June 30, 2021 Attention: President The Stock Exchange of Thailand AI Energy Public Company Limited (AIE) would like to submit the financial statement for 2nd

NCI to Reported Net Profit.............................................. 12 Table 6: Cash Flow Statement

ASEAN DEBT SECURITIES DISCLOSURE STANDARDS 1 แบบ 69-BASE-FD แบบแสดงรายการขอ้มลูและรา่งหนงัสอืชีช้วน ส าหรบัการออกและเสนอขายตราสารหนีใ้นลกัษณะโครงการ Registration Statement for Issuing and Offering of

) That is aimed at cooperation, and (ii) That is clearly aimed at profit or cost-sharing or shares common ownership , control or management, common quality control policies and procedures, common https